- Home
- Publications
-
Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Pavel Golubchik, Jonathan Sever, Abraham Weizman
- Title
- Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.
- Journal
- Clinical Neuropharmacology
- Year
- 2013
- Month
- March
- Volume
- 36
- Issue
- 2
- Page(s)
- pp. 37-41.
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Open Trial, Peer-Reviewed
- Keywords
- Adolescent / Secondary School Age, Antidepressants, Asperger Syndrome, Attention Deficit Hyperactivity Disorder, Autism, Child/Children, Depression, Development, Hyperactivity, Intervention, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Primary / Elementary School Age, Reboxetine, Selective Noradrenaline Re-Uptake Inhibitor, Uptake
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.